The origins of Invion started with Cbio back in 2000-and was not listed on the ASX till 15/02/2010---10 years after inception.There was a secondary market for those who wanted to sell privately prior to that,cannot recall exactly how that operated.I think the main reason Nadalol did not find a partner was due to its generic status.Patent applications were for dosage and delivery methods-I have attached a link of a pod cast for those who have their doubts re nadalol with Dr Mitchell Glass who has bought 5 drugs to market (no mean feat). The Shareholders you mention who are dumping are probably mostly day and short term traders.Personally, I have no problems with what is happening at the moment.
The origins of Invion started with Cbio back in 2000-and was not...
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.001(20.0%) |
Mkt cap ! $38.54M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $5.101K | 850.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2721876 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 10589568 | 12 |
View Market Depth
| Last trade - 12.33pm 13/05/2024 (20 minute delay) ? |
| IVX (ASX) Chart |